This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Edward J. Weinman, MD; Harry O. Senekjian, MD; Thomas F. Knight, MD; Christine E. Lacke, PA-C

Arch Intern Med. 1980;140(11):1422.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Several new trends in the treatment of patients with end-stage renal disease have begun to emerge in the last few years. Most notable has been the reintroduction of peritoneal dialysis (PD) as a long-term treatment option. The increased use of PD is the result of the development of a long-term indwelling peritoneal catheter, automated dialysate delivery systems, and the view by some investigators that, in certain patients, PD as compared with hemodialysis may be a preferred mode of therapy. In 1978, continuous ambulatory peritoneal dialysis (CAPD) was introduced and demonstrated to be an alternative to traditional intermittent peritoneal dialysis (IPD).¹ With CAPD, the patient instills the dialysis solution for four to six hours and exchanges the solution four to five times per day, six or seven days per week. Thus, while the efficiency of dialysis per hour is less with CAPD than with IPD, the clearances per week of . . . [Full Text PDF of this Article]

Author Affiliations
VA Medical Center Research Bldg 211 Houston, TX 77211

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?